(a) (1) A pharmacy and therapeutics committee shall:
(i) include clinical specialists that represent the needs of a purchaser’s beneficiaries; and
(ii) include at least one practicing pharmacist and one practicing physician who are independent of any developer or manufacturer of prescription drugs.
(2) A majority of the members of a pharmacy and therapeutics committee shall be practicing physicians or practicing pharmacists.
(b) Each member of a pharmacy and therapeutics committee shall sign a conflict of interest statement updated at least annually disclosing any economic interest or relationship that could influence the pharmacy and therapeutics committee’s decisions.
Structure Maryland Statutes
Subtitle 16 - Pharmacy Benefits Managers
Part III - Pharmacy and Therapeutics Committees
Section 15-1614 - Composition; Conflict of Interest Statement
Section 15-1615 - Mandatory Participation on Committee Prohibited
Section 15-1616 - Disclosure About Composition
Section 15-1617 - Required Policies, Procedures, and Processes